Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP554623.RApe3GFgek6Q9dI0iJWC5xSR_fEb1no4PTUgNVBX5GPkM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP554623.RApe3GFgek6Q9dI0iJWC5xSR_fEb1no4PTUgNVBX5GPkM130_assertion type Assertion NP554623.RApe3GFgek6Q9dI0iJWC5xSR_fEb1no4PTUgNVBX5GPkM130_head.
- NP554623.RApe3GFgek6Q9dI0iJWC5xSR_fEb1no4PTUgNVBX5GPkM130_assertion description "[Although pharmacogenetics is a promising field that already contributed to a better understanding of some of the underlying mechanisms of action of drugs used in IBD, the only discovery translated until now into daily practice is the relation between thiopurine S-methyltransferase (TPMT) gene polymorphisms and hematological toxicity of thiopurine treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554623.RApe3GFgek6Q9dI0iJWC5xSR_fEb1no4PTUgNVBX5GPkM130_provenance.
- NP554623.RApe3GFgek6Q9dI0iJWC5xSR_fEb1no4PTUgNVBX5GPkM130_assertion evidence source_evidence_literature NP554623.RApe3GFgek6Q9dI0iJWC5xSR_fEb1no4PTUgNVBX5GPkM130_provenance.
- NP554623.RApe3GFgek6Q9dI0iJWC5xSR_fEb1no4PTUgNVBX5GPkM130_assertion SIO_000772 16773681 NP554623.RApe3GFgek6Q9dI0iJWC5xSR_fEb1no4PTUgNVBX5GPkM130_provenance.
- NP554623.RApe3GFgek6Q9dI0iJWC5xSR_fEb1no4PTUgNVBX5GPkM130_assertion wasDerivedFrom befree-2016 NP554623.RApe3GFgek6Q9dI0iJWC5xSR_fEb1no4PTUgNVBX5GPkM130_provenance.
- NP554623.RApe3GFgek6Q9dI0iJWC5xSR_fEb1no4PTUgNVBX5GPkM130_assertion wasGeneratedBy ECO_0000203 NP554623.RApe3GFgek6Q9dI0iJWC5xSR_fEb1no4PTUgNVBX5GPkM130_provenance.